\-\ Texto\\:\\ \ \(0\)\
\-\ general\\:\\ the\\ patient\\ is\\ a\\ white\\ male\\.\\ he\\ is\\ 170\\.2cm\\ tall\\ and\\ weighs\\ about\\ 98\\.7\\ kg\\ \\(bmi\\ 34\\.1\\)\\.\\ blood\\ pressure\\ on\\ the\\ left\\ arm\\ in\\ the\\ seated\\ position\\ is\\ 129\\/64\\.\\ appears\\ stated\\ age\\.\\ he\\ is\\ well\\ appearing\\ and\\ in\\ no\\ acute\\ distress\\.\ \(0\)\
\-\ heent\\ \\:\\ normocephalic\\,\\ non\\ traumatic\\.\\ pupils\\ were\\ equal\\ and\\ reactive\\ to\\ light\\.\\ \ \(0\)\
\-\ cardiac\\:\\ regular\\ rate\\ and\\ rhythm\\,\\ normal\\ s1\\ and\\ s2\\.\\ no\\ murmurs\\,\\ rubs\\,\\ or\\ gallops\\.\\ right\\ sided\\ scars\\ visible\\ from\\ healed\\ vats\\.\\ median\\ sternotomy\\ incision\\ is\\ well\\ healed\\.\\ \ \(0\)\
\-\ pulmonary\\ \\:\\ pattern\\ unlabored\\,\\ breath\\ sounds\\ are\\ clear\\ and\\ equal\\ bilaterally\\,\\ no\\ distress\\.\\ no\\ rales\\,\\ no\\ rhonchi\\,\\ no\\ wheezez\\.\ \(0\)\
\-\ abdomen\\:\\ non\\-distended\ \(0\)\
\-\ extremities\\:\\ no\\ cyanosis\\,\\ no\\ clubbing\\,\\ no\\ edema\\,\\ no\\ coolness\\ and\\ no\\ deformities\\.\\ \ \(0\)\
\-\ musculoskeletal\\:\\ 5\\+\\ muslce\\ strength\\ in\\ all\\ extremities\\,\\ gait\\ and\\ tone\\ are\\ normal\\.\ \(0\)\
\-\ this\\ patient\\ was\\ initially\\ treated\\ with\\ right\\ thoracotomy\\,\\ which\\ yielded\\ 2l\\ of\\ fluid\\.\\ this\\ procedure\\ significantly\\ improved\\ his\\ shortness\\ of\\ breath\\.\\ \ \(0\)\
\-\ he\\ then\\ underwent\\ a\\ right\\ vats\\ pleurectomy\\ and\\ was\\ then\\ referred\\ to\\ outpatient\\ an\\ outpatient\\ medical\\ oncologist\\ who\\ is\\ currently\\ managing\\ his\\ treatment\\.\ \(0\)\
\-\ he\\ currently\\ on\\ chemotherapy\\ under\\ supervision\\ of\\ a\\ medical\\ oncologist\\,\\ and\\ reports\\ that\\ he\\ is\\ doing\\ well\\.\ \(0\)\
\-\ images\\ 1\\ and\\ 2\\ represent\\ a\\ pre\\-operative\\ pet\\-ct\\.\\ the\\ patient\\ was\\ given\\ iv\\ 18f\\-fdg\\ followed\\ by\\ low\\-dose\\,\\ non\\ contrast\\ ct\\ from\\ the\\ skull\\ vertex\\ to\\ the\\ mid\\-thigh\\.\\ this\\ ct\\ was\\ obtained\\ for\\ attenuation\\ correction\\ and\\ anatomic\\ orientation\\ with\\ axial\\ reconstruction\\.\\ pet\\ followed\\,\\ encompassing\\ the\\ same\\ regions\\.\\ the\\ chest\\ was\\ found\\ to\\ show\\ mild\\ to\\ moderate\\ abnormal\\ fdg\\ uptake\\ within\\ the\\ right\\-sided\\ pleural\\ effusion\\/thickening\\.\\ \\ there\\ was\\ a\\ small\\ internal\\ decrease\\ in\\ size\\.\\ there\\ was\\ no\\ axillary\\,\\ mediastinal\\,\\ or\\ hilar\\ lymphadenopathy\\.\\ there\\ is\\ no\\ air\\-space\\ disease\\ or\\ suspicious\\ lung\\ nodule\\.\\ these\\ findings\\ are\\ consistent\\ with\\ low\\-grade\\ metabolically\\ active\\ malignant\\ epithelioid\\ neoplasm\\ consistent\\ with\\ mesothelioma\\ of\\ the\\ right\\-sided\\ pleura\\.\\ \ \(0\)\
\-\ image\\ 3\\ represents\\ erect\\ pa\\ and\\ lateral\\ chest\\ images\\ following\\ vats\\ pleurectomy\\.\\ these\\ films\\ demonstrate\\ post\\-sternotomy\\ midline\\ wires\\ and\\ clips\\.\\ of\\ note\\ there\\ is\\ mild\\ to\\ moderate\\ cardiomegaly\\ and\\ chronic\\ right\\ basolateral\\ pleural\\ thickening\\ of\\ the\\ inferior\\ right\\ minor\\ fissure\\.\\ a\\ mediport\\-type\\ catheter\\ is\\ visualized\\ overlying\\ the\\ superior\\ right\\ hemithorax\\ with\\ its\\ distal\\ extent\\ projecting\\ over\\ the\\ course\\ of\\ the\\ right\\ jugular\\ vein\\.\\ there\\ is\\ also\\ minor\\ bronchitis\\ interstitial\\ features\\ at\\ the\\ lung\\ bases\\.\\ there\\ is\\ no\\ acute\\ pathology\\ noted\\,\\ and\\ there\\ is\\ no\\ evidence\\ of\\ pneumothorax\\ or\\ definitive\\ infiltrates\\.\ \(0\)\
\-\ image\\ 4\\ represents\\ a\\ follow\\ up\\ study\\ approximately\\ 2\\ weeks\\ after\\ image\\ 3\\ was\\ obtained\\.\\ there\\ was\\ evidence\\ of\\ copd\\.\\ it\\ was\\ noted\\ that\\ there\\ was\\ pleural\\-parenchymal\\ scarring\\ of\\ the\\ right\\ lung\\ base\\.\\ the\\ same\\ medial\\ sternotomy\\ changes\\ were\\ noted\\,\\ as\\ was\\ the\\ mediport\\ placement\\ and\\ cardiomegaly\\.\\ at\\ this\\ point\\ there\\ was\\ no\\ active\\ pulmonary\\ disease\\ noted\\.\\ \ \(0\)\
\-\ images\\ 5\\,\\ 6\\,\\ and\\ 7\\ represent\\ post\\-operative\\ pet\\-ct\\ following\\ right\\-sided\\ vats\\ pleurectomy\\.\\ the\\ same\\ protocol\\ was\\ followed\\ as\\ for\\ the\\ pet\\-ct\\ shown\\ in\\ images\\ 1\\ and\\ 2\\.\\ there\\ was\\ found\\ to\\ be\\ minimal\\ abnormal\\ fdg\\ uptake\\ within\\ the\\ right\\-sided\\ pleura\\.\\ there\\ was\\ no\\ axillary\\,\\ supraclavicular\\,\\ mediastinal\\,\\ or\\ hilar\\ lymphadenopathy\\.\\ the\\ image\\ has\\ the\\ overall\\ appearance\\ of\\ postsurgical\\ inflammatory\\ changes\\,\\ although\\ residual\\ low\\-grade\\ metabolically\\ active\\ metastasis\\ cannot\\ be\\ excluded\\.\ \(0\)\
\-\ malignant\\ mesothelioma\\,\\ epithelioid\\ type\ \(0\)\
\-\ asbestosis\ \(10\)\
\-\ malignant\\ mesothelioma\ \(14\)\
\-\ this\\ patient\\ is\\ a\\ 77\\ year\\ old\\ male\\ who\\ presented\\ to\\ his\\ primary\\ care\\ physician\\ as\\ part\\ of\\ a\\ pre\\-operative\\ work\\-up\\ for\\ cataract\\ surgery\\.\\ on\\ cxr\\ it\\ was\\ noted\\ that\\ the\\ patient\\ has\\ a\\ pleural\\ effusion\\.\\ the\\ patient\\ did\\ note\\ that\\ he\\ had\\ increasing\\ shortness\\ of\\ breath\\,\\ but\\ did\\ not\\ think\\ to\\ address\\ this\\ issue\\ prior\\ to\\ his\\ pre\\-op\\ clearance\\.\\ \ \(0\)\
\-\ pmhx\\:\\ \ \(0\)\
\-\ gerd\\,\\ gout\\,\\ hyperlipidemia\\,\\ benign\\ tumor\\ of\\ colon\\,\\ osteoarthritis\\,\\ rheumatic\\ fever\\,\\ htn\\,\\ congestive\\ heart\\ failure\\,\\ cad\\,\\ myocardial\\ infarction\ \(0\)\
\-\ pshx\\:\\ \ \(0\)\
\-\ neck\\ surgery\\ in\\ childhood\\ \\(ages\\ 5\\ and\\ 10\\)\\,\\ cholecystecomy\\ s\\/p\\ gallbladder\\ rupture\\,\\ quadruple\\ bypass\\ surgery\\,\\ hemicolectomy\\,\\ avulsed\\ fingers\\,\\ vats\\,\\ right\\ pleurectomy\ \(0\)\
\-\ medications\\:\\ almethicone\\ 125mg\\,\\ albuterol\\-ipratropium\\,\\ oxycodone\\ 10mg\\,\\ senna\\ oral\\,\\ tamsulosin\\,\\ alprazolam\\,\\ isosorbide\\ mononitrate\\,\\ plavix\\,\\ aspirin\\,\\ lipitor\\,\\ allopurinol\\,\\ atenolol\\,\\ ranitidine\\,\\ fluoxetine\\,\\ nitroglycerin\\,\\ ferrous\\ sulfate\\.\\ \ \(0\)\
\-\ allergies\\:\\ adhesive\\ tape\\ \\(rash\\)\ \(0\)\
\-\ transfustions\\:\\ mr\\.\\ b\\ has\\ 2\\ blood\\ transfusions\\ as\\ a\\ result\\ of\\ rectal\\ bleeding\\ from\\ gi\\ tumors\\.\ \(0\)\
\-\ social\\:\\ 34\\ pack\\ year\\ smoking\\ histroy\\ \\(2\\ ppd\\ for\\ 17\\ years\\)\\,\\ quit\\ smoking\\ in\\ 1970\\.\\ history\\ of\\ alcohol\\ abuse\\,\\ sober\\ since\\ 2012\\ when\\ he\\ underwent\\ treatment\\ for\\ etoh\\ withdrawal\\.\\ he\\ denies\\ any\\ illicit\\ and\\/or\\ iv\\ drug\\ abuse\\.\\ mr\\.\\ b\\ has\\ 3\\ children\\.\\ he\\ lives\\ in\\ an\\ apartment\\ on\\ his\\ house\\,\\ which\\ his\\ daughter\\ occupies\\.\\ he\\ worked\\ as\\ at\\ chemical\\ plant\\ for\\ 40\\ years\\.\\ he\\ recalls\\ this\\ plant\\ is\\ adjacent\\ to\\ another\\ chemical\\ plant\\ which\\ used\\ asbestos\\ as\\ part\\ of\\ its\\ plastics\\ manufacturing\\ process\\.\ \(0\)\
\-\ this\\ patient\\ is\\ a\\ 77\\ year\\ old\\ white\\ male\\.\\ he\\ worked\\ in\\ a\\ factory\\ adject\\ to\\ a\\ chemical\\ plant\\,\\ which\\ used\\ asbestos\\ in\\ the\\ manufacturing\\ of\\ plastic\\ products\\.\\ he\\ states\\ that\\ he\\ remembers\\ hearing\\ that\\ during\\ the\\ day\\,\\ the\\ plant\\ would\\ vacuum\\ excess\\ asbestos\\ from\\ the\\ factory\\ floor\\ to\\ the\\ roof\\ of\\ the\\ building\\ and\\ then\\ vent\\ the\\ asbestos\\ out\\ the\\ stacks\\ of\\ the\\ factory\\ at\\ night\\.\\ in\\ fact\\,\\ the\\ patient\\'s\\ grown\\ son\\,\\ now\\ in\\ his\\ fifties\\,\\ recalls\\ there\\ often\\ being\\ a\\ thin\\ coating\\ of\\ \\?dust\\?\\ on\\ park\\ benches\\ in\\ the\\ morning\\ following\\ the\\ venting\\ from\\ the\\ plant\\.\\ \ \(0\)\
\-\ the\\ patient\\ states\\ that\\ he\\ worked\\ in\\ a\\ plant\\ approximately\\ 600\\ feet\\ from\\ the\\ asbestos\\-using\\ facility\\,\\ and\\ states\\ that\\ his\\ factory\\ was\\ under\\ negative\\ pressure\\,\\ resulting\\ in\\ outside\\ asbestos\\-containing\\ air\\ to\\ be\\ \\?sucked\\ into\\?\\ his\\ factory\\.\\ he\\ began\\ work\\ in\\ the\\ 1960s\\ and\\ worked\\ at\\ the\\ same\\ plant\\ for\\ 41\\ years\\ until\\ his\\ retirement\\ in\\ 2003\\.\\ he\\ also\\ lived\\ approximately\\ 1\\ mile\\ from\\ both\\ plants\\,\\ and\\ states\\ that\\ his\\ home\\ was\\ directly\\ downwind\\ from\\ the\\ factories\\.\\ unfortunately\\,\\ this\\ patient\\ reported\\ that\\ a\\ former\\ coworker\\ died\\ of\\ complications\\ from\\ mesothelioma\\.\\ \ \(0\)\
\-\ this\\ patient\\'s\\ mesothelioma\\ was\\ discovered\\ incidentally\\ as\\ part\\ of\\ pre\\-operative\\ clearance\\ for\\ a\\ propsed\\ opthalmologic\\ surgery\\.\\ as\\ part\\ of\\ his\\ pre\\-operative\\ work\\-up\\ a\\ chest\\ xray\\ was\\ ordered\\,\\ which\\ revealed\\ a\\ large\\ plueral\\ effusion\\.\\ he\\ recalls\\ that\\ at\\ the\\ time\\ of\\ discovery\\ he\\ did\\ have\\ shortness\\ of\\ breath\\ with\\ minimal\\ exersion\\,\\ stating\\ that\\ he\\ would\\ become\\ short\\ of\\ breath\\ \\?just\\ by\\ talking\\?\\.\\ \ \(0\)\
\-\ this\\ patient\\'s\\ case\\ is\\ typical\\ of\\ malignant\\ pleural\\ mesothelioma\\.\\ this\\ disease\\ typically\\ affects\\ patients\\ who\\ are\\ 60\\ years\\ and\\ older\\.\\ often\\,\\ these\\ patients\\ present\\ decades\\ after\\ an\\ exposure\\ to\\ asbestos\\ and\\ have\\ gradual\\,\\ worsening\\,\\ nonspecific\\ pulmonary\\ symptoms\\ including\\ but\\ not\\ limited\\ to\\:\\ chest\\ pain\\,\\ dyspnea\\,\\ cough\\,\\ hoarseness\\,\\ or\\ dysphagia\\.\ \(0\)\
\-\ physical\\ findings\\ at\\ the\\ time\\ of\\ diagnosis\\ generally\\ are\\ related\\ to\\ a\\ pleural\\ effusion\\,\\ which\\ is\\ often\\ present\\.\\ physical\\ exam\\ findings\\ may\\ include\\ unilateral\\ dullness\\ to\\ percussion\\ at\\ the\\ lung\\ base\\,\\ decreased\\ air\\ movement\\ on\\ side\\ of\\ involvement\\,\\ or\\ asymmetric\\ chest\\ wall\\ expansion\\ during\\ respiration\\ \\(2\\-6\\)\\.\ \(0\)\
\-\ the\\ primary\\ risk\\ factor\\ for\\ mesothelioma\\ is\\ asbestos\\ exposure\\.\\ the\\ fibers\\ of\\ asbestos\\,\\ a\\ naturally\\ occuring\\ mineral\\,\\ are\\ strong\\ and\\ resistant\\ to\\ heat\\,\\ and\\ have\\ been\\ used\\ in\\ the\\ production\\ of\\ insulation\\,\\ brakes\\,\\ shingles\\,\\ flooring\\ and\\ many\\ other\\ products\\.\\ if\\ asbestos\\ is\\ broken\\ up\\,\\ and\\ the\\ dust\\ is\\ inhaled\\ or\\ swallowed\\,\\ the\\ fibers\\ will\\ settle\\ in\\ the\\ lungs\\,\\ leading\\ to\\ irritation\\,\\ which\\ can\\ then\\ progress\\ to\\ mesothelioma\\.\\ the\\ exact\\ mechanism\\ of\\ this\\ malignant\\ transformation\\ is\\ poorly\\ understood\\.\\ the\\ development\\ of\\ mesothelioma\\ following\\ asbestos\\ exposure\\ may\\ be\\ a\\ \\ 20\\ \\-\\ 40\\ year\\ process\\.\\ of\\ note\\,\\ most\\ people\\ with\\ years\\ of\\ asbestos\\ exposure\\ never\\ develop\\ mesothelioma\\,\\ while\\ some\\ people\\,\\ with\\ only\\ minimal\\ exposure\\,\\ develop\\ the\\ disease\\.\\ given\\ this\\ variation\\,\\ a\\ predisposition\\ to\\ cancer\\ likely\\ plays\\ a\\ role\\ in\\ disease\\ progression\\.\\ additional\\ risk\\ factors\\ include\\,\\ living\\ with\\ someone\\ working\\ with\\ asbestos\\ \\(as\\ they\\ may\\ carry\\ the\\ fibers\\ home\\ on\\ their\\ clothing\\ and\\ skin\\)\\,\\ as\\ well\\ as\\ family\\ history\\ of\\ mesothelioma\\ \\(7\\-\\ 9\\)\\.\ \(0\)\
\-\ in\\ terms\\ of\\ imaging\\,\\ computed\\ tomography\\ \\(ct\\)\\ is\\ often\\ pursued\\ given\\ limited\\ sensitivity\\ and\\ specificity\\ with\\ cxr\\.\\ findings\\ include\\ unilateral\\ pleural\\ abnormalities\\ with\\ a\\ large\\ unilateral\\ pleural\\ effusion\\.\\ there\\ may\\ be\\ a\\ plural\\ mass\\ or\\ \\"rind\\"\\,\\ or\\ even\\ a\\ diffuse\\ pleural\\ thickening\\ in\\ the\\ absence\\ of\\ pleural\\ effusion\\.\\ there\\ can\\ be\\ ipsilateral\\ mediastinal\\ shift\\ due\\ to\\ encasement\\ of\\ the\\ lung\\ by\\ a\\ thick\\ \\"rind\\"of\\ tumor\\ and\\ relative\\ ipsilateral\\ lung\\ volume\\ loss\\.\\ when\\ positron\\ emission\\ tomography\\ \\(pet\\)\\ is\\ used\\ in\\ conjunction\\ with\\ ct\\,\\ \\ increased\\ uptake\\ of\\ fluorodeoxyglucose\\ \\(fdg\\)\\ is\\ observed\\.\ \(0\)\
\-\ for\\ the\\ diagnosis\\ of\\ malignant\\ mesothelioma\\,\\ clinical\\ suspicion\\ may\\ arise\\ with\\ respiratory\\ symptoms\\,\\ pleural\\ thickening\\ and\\/or\\ effusion\\ on\\ chest\\ imaging\\,\\ and\\ a\\ history\\ of\\ asbestos\\ exposure\\.\\ however\\,\\ ultimately\\,\\ a\\ biopsy\\ is\\ necessary\\ to\\ confirm\\ the\\ diagnosis\\.\ \(0\)\
\-\ once\\ diagnosed\\,\\ an\\ integrated\\ positron\\ emission\\ tomography\\ with\\ computed\\ tomography\\ \\(pet\\-ct\\)\\ is\\ the\\ initial\\ staging\\ assessment\\.\ \(0\)\
\-\ when\\ diagnosed\\ at\\ an\\ early\\ stage\\,\\ surgeons\\ may\\ remove\\ the\\ mesothelioma\\,\\ and\\ in\\ some\\ cases\\,\\ this\\ may\\ be\\ curative\\.\\ other\\ therapies\\ include\\ chemotherapy\\ and\\ radiation\\ therapy\\.\\ there\\ are\\ ongoing\\ clinical\\ trials\\ investigating\\ targeted\\ biological\\ and\\ gene\\ therapy\\.\ \(0\)\
\-\ overall\\,\\ however\\,\\ the\\ prognosis\\ is\\ poor\\.\\ the\\ survival\\ is\\ on\\ the\\ spectrum\\ of\\ 9\\ to\\ 17\\ months\\ after\\ diagnosis\\ and\\ few\\ patients\\ are\\ cured\\ \\(12\\)\\.\ \(0\)\
\-\ references\\ for\\ malignant\\ pleural\\ mesothelioma\ \(0\)\
\-\ 1\\.\\ husain\\ an\\,\\ colby\\ t\\,\\ ordonez\\ n\\,\\ et\\ al\\.\\ guidelines\\ for\\ pathologic\\ diagnosis\\ of\\ malignant\\ mesothelioma\\:\\ 2012\\ update\\ of\\ the\\ consensus\\ statement\\ from\\ the\\ international\\ mesothelioma\\ interest\\ group\\.\\ arch\\ pathol\\ lab\\ med\\ 2013\\;\\ 137\\:647\\.\ \(0\)\
\-\ 2\\.\\	socola\\ f\\,\\ loaiza\\-bonilla\\ a\\,\\ bustinza\\-linares\\ e\\,\\ et\\ al\\.\\ recurrent\\ thrombotic\\ thrombocytopenic\\ purpura\\-like\\ syndrome\\ as\\ a\\ paraneoplastic\\ phenomenon\\ \\ in\\ malignant\\ peritoneal\\ mesothelioma\\:\\ a\\ case\\ report\\ and\\ review\\ of\\ the\\ literature\\.\\ case\\ rep\\ oncol\\ med\\ 2012\\;\\ \\ 2012\\:619348\\.\ \(0\)\
\-\ 3\\.\\	wong\\ sf\\,\\ newland\\ l\\,\\ john\\ t\\,\\ white\\ sc\\.\\ paraneoplastic\\ leukocytoclastic\\ vasculitis\\ as\\ an\\ initial\\ presentation\\ \\ of\\ malignant\\ pleural\\ mesothelioma\\:\\ \\ a\\ case\\ report\\.\\ j\\ med\\ case\\ rep\\ 2012\\;\\ 6\\:261\\.\ \(0\)\
\-\ 4\\.\\	li\\ jy\\,\\ yong\\ ty\\,\\ kuss\\ bj\\,\\ et\\ al\\.\\ malignant\\ pleural\\ mesothelioma\\ with\\ associated\\ minimal\\ change\\ disease\\ and\\ acute\\ renal\\ \\ failure\\.\\ ren\\ \\ fail\\ 2010\\;\\ 32\\:1012\\.\ \(0\)\
\-\ 5\\.\\	bech\\ c\\,\\ s0rensen\\ jb\\.\\ polyneuropathy\\ \\ in\\ a\\ patient\\ with\\ malignant\\ pleural\\ mesothelioma\\:\\ \\ a\\ paraneoplastic\\ \\ syndrome\\.\\ j\\ thorac\\ oncol\\ \\ 2008\\;\\ \\ 3\\:1359\\.\ \(0\)\
\-\ 6\\.\\	tanriverdi\\ 0\\,\\ meydan\\ n\\,\\ barutca\\ s\\,\\ et\\ al\\.\\ anti\\-yo\\ antibody\\-mediated\\ paraneoplastic\\ cerebellar\\ degeneration\\ in\\ a\\ female\\ patient\\ with\\ pleural\\ malignant\\ mesothelioma\\.\\ jpn\\ j\\ clin\\ oncol\\ 2013\\;\\ 43\\:563\\.\ \(0\)\
\-\ 7\\.\\	malignant\\ pleural\\ mesothelioma\\.\\ fort\\ washington\\,\\ pa\\.\\:\\ national\\ comprehensive\\ cancer\\ network\\.\\ http\\:\\/\\/www\\.nccn\\.org\\/professionals\\/physician\\_gls\\/f\\_guidelines\\.asp\\.\\ \\ \\ accessed\\ sept\\ \\ 17\\,\\ 2015\\.\ \(0\)\
\-\ 8\\.\\	niederhuber\\ \\ je\\,\\ et\\ al\\.\\,\\ eds\\.\\ diseases\\ of\\ the\\ pleura\\ and\\ mediastinum\\.\\ in\\:\\ abeloff\\ s\\ clinical\\ oncology\\.\\ 5th\\ ed\\.\\ philadelphia\\,\\ pa\\.\\:\\ churchill\\ livingstone\\ elsevier\\;\\ 2014\\.\\ http\\:\\/\\/www\\.clinicalkey\\.com\\.\\ \\ \\ accessed\\ \\ \\ sept\\.\\ \\ 17\\,\\ 2015\\.\ \(0\)\
\-\ 9\\.\\	osha\\ fact\\ sheet\\:\\ asbestos\\.\\ occupational\\ safety\\ and\\ health\\ administration\\.\\ http\\:\\/\\/www\\.osha\\.gov\\/sl\\ tc\\/asbestos\\/hazards\\.html\\.\\ accessed\\ oct\\.\\ 7\\,\\ 2015\\.\ \(0\)\
\-\ 10\\.\\	presentation\\,\\ initial\\ evaluation\\,\\ and\\ prognosis\\ of\\ malignant\\ pleural\ \(0\)\
\-\ mesothelioma\\.\\ \\"malignant\\ mesothelioma\\ i\\ ct\\.\\ ed\\.\\ uptodate\\ \\.\\.\\ \\.\\ uptodate\\,\\ 5\\ oct\\ 2016\\.\\ web\\.\\ 05\\ june\\ 2017\\.\ \(0\)\
\-\ 11\\.\\	husain\\ an\\,\\ colby\\ t\\,\\ ordonez\\ n\\,\\ et\\ al\\.\\ guidelines\\ for\\ pathologic\\ diagnosis\\ of\\ malignant\\ mesothelioma\\:\\ 2012\\ update\\ of\\ the\\ consensus\\ statement\\ from\\ the\\ international\\ mesothelioma\\ interest\\ group\\.\\ arch\\ pathol\\ lab\\ med\\ 2013\\;\\ 137\\:647\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ mesothelioma\\:\\ 0\\.06629854411360155\ \(0\)\
\-\ asbestos\\:\\ 0\\.03519557421567471\ \(0\)\
\-\ plant\\:\\ 0\\.03097186365455311\ \(0\)\
\-\ pleural\\:\\ 0\\.026888442982576755\ \(0\)\
\-\ malignant\\:\\ 0\\.025027360104122078\ \(0\)\
\-\ he\\:\\ 0\\.022728192011754238\ \(0\)\
\-\ factory\\:\\ 0\\.018391101371063843\ \(0\)\
\-\ \\,\\:\\ 0\\.01832260691299085\ \(0\)\
\-\ vats\\:\\ 0\\.015521766756369048\ \(0\)\
\-\ pleurectomy\\:\\ 0\\.014164392874826705\ \(0\)\
\-\ pet\\-ct\\:\\ 0\\.014164392874826705\ \(0\)\
\-\ his\\:\\ 0\\.014087067841641173\ \(0\)\
\-\ \\:\\:\\ 0\\.014007218882629785\ \(0\)\
\-\ 2012\\:\\ 0\\.0129843245805053\ \(0\)\
\-\ exposure\\:\\ 0\\.012715168459960373\ \(0\)\
\-\ paraneoplastic\\:\\ 0\\.011775902944425622\ \(0\)\
\-\ worked\\:\\ 0\\.011193669103527279\ \(0\)\
\-\ pre\\-operative\\:\\ 0\\.010670433935363769\ \(0\)\
\-\ et\\:\\ 0\\.010002092745821587\ \(0\)\
\-\ was\\:\\ 0\\.0098921963615288\ \(0\)\
\-\ there\\:\\ 0\\.009698498047397435\ \(0\)\
\-\ recalls\\:\\ 0\\.009632140441782643\ \(0\)\
\-\ \\?\\:\\ 0\\.009537310297305548\ \(0\)\
\-\ oncol\\:\\ 0\\.009463718560481808\ \(0\)\
\-\ med\\:\\ 0\\.009348894982913922\ \(0\)\
\-\ effusion\\:\\ 0\\.00928648404253213\ \(0\)\
\-\ tomography\\:\\ 0\\.008707384522244307\ \(0\)\
\-\ al\\:\\ 0\\.008633368858618418\ \(0\)\
\-\ that\\:\\ 0\\.00844221579728593\ \(0\)\
\-\ 2015\\:\\ 0\\.008185618642433053\ \(0\)\
\-\ as\\:\\ 0\\.00800929817760899\ \(0\)\
\-\ right\\-sided\\:\\ 0\\.007952578693660868\ \(0\)\
\-\ fdg\\:\\ 0\\.007946742448920423\ \(0\)\
\-\ 17\\:\\ 0\\.007934333791818828\ \(0\)\
\-\ part\\:\\ 0\\.007898359560542596\ \(0\)\
\-\ accessed\\:\\ 0\\.007840772993981832\ \(0\)\
\-\ 2013\\:\\ 0\\.0077905947483031795\ \(0\)\
\-\ is\\:\\ 0\\.007772370149264559\ \(0\)\
\-\ manufacturing\\:\\ 0\\.007742965913638277\ \(0\)\
\-\ husain\\:\\ 0\\.007742965913638277\ \(0\)\
\-\ colby\\:\\ 0\\.007742965913638277\ \(0\)\
\-\ ordonez\\:\\ 0\\.007742965913638277\ \(0\)\
\-\ 137\\:647\\:\\ 0\\.007742965913638277\ \(0\)\
\-\ \\;\\:\\ 0\\.007723245713832578\ \(0\)\
\-\ states\\:\\ 0\\.00766392350499477\ \(0\)\
\-\ breath\\:\\ 0\\.00761467482900226\ \(0\)\
\-\ chemical\\:\\ 0\\.0075216926060206165\ \(0\)\
\-\ pleura\\:\\ 0\\.007366954401101314\ \(0\)\
\-\ metabolically\\:\\ 0\\.0073564405484255364\ \(0\)\
\-\ a\\:\\ 0\\.00718340918451232\ \(0\)\
\-\ n\\:\\ 0\\.00710014893554305\ \(0\)\
\-\ dust\\:\\ 0\\.007082196437413353\ \(0\)\
\-\ statement\\:\\ 0\\.007082196437413353\ \(0\)\
\-\ rep\\:\\ 0\\.007082196437413353\ \(0\)\
\-\ lung\\:\\ 0\\.0070786247480612375\ \(0\)\
\-\ no\\:\\ 0\\.006972140401317747\ \(0\)\
\-\ fibers\\:\\ 0\\.006875384040134452\ \(0\)\
\-\ this\\:\\ 0\\.006871810390711152\ \(0\)\
\-\ update\\:\\ 0\\.006869476178772543\ \(0\)\
\-\ same\\:\\ 0\\.006715373878440431\ \(0\)\
\-\ from\\:\\ 0\\.006640034721018272\ \(0\)\
\-\ rind\\:\\ 0\\.0065487209484377355\ \(0\)\
\-\ positron\\:\\ 0\\.0065487209484377355\ \(0\)\
\-\ sept\\:\\ 0\\.0065487209484377355\ \(0\)\
\-\ epithelioid\\:\\ 0\\.006421426961188429\ \(0\)\
\-\ minimal\\:\\ 0\\.006414642460249376\ \(0\)\
\-\ pathol\\:\\ 0\\.006309145706987872\ \(0\)\
\-\ may\\:\\ 0\\.006253717150756372\ \(0\)\
\-\ used\\:\\ 0\\.006250112787317372\ \(0\)\
\-\ unilateral\\:\\ 0\\.0060640716570015945\ \(0\)\
\-\ oncologist\\:\\ 0\\.006034901595975689\ \(0\)\
\-\ emission\\:\\ 0\\.006034901595975689\ \(0\)\
\-\ uptodate\\:\\ 0\\.006034901595975689\ \(0\)\
\-\ years\\:\\ 0\\.005980083739319549\ \(0\)\
\-\ consensus\\:\\ 0\\.0059585977755052056\ \(0\)\
\-\ interest\\:\\ 0\\.0059585977755052056\ \(0\)\
\-\ chest\\:\\ 0\\.005847652049735515\ \(0\)\
\-\ then\\:\\ 0\\.005797839615676053\ \(0\)\
\-\ patient\\:\\ 0\\.0057160567363343335\ \(0\)\
\-\ clearance\\:\\ 0\\.005702864709161375\ \(0\)\
\-\ guidelines\\:\\ 0\\.005702864709161375\ \(0\)\
\-\ international\\:\\ 0\\.005702864709161375\ \(0\)\
\-\ t\\:\\ 0\\.005656395642904898\ \(0\)\
\-\ sternotomy\\:\\ 0\\.005648376230762949\ \(0\)\
\-\ in\\:\\ 0\\.005623985912262697\ \(0\)\
\-\ diagnosis\\:\\ 0\\.005611685407379656\ \(0\)\
\-\ j\\:\\ 0\\.005519101095851149\ \(0\)\
\-\ people\\:\\ 0\\.005414703725488416\ \(0\)\
\-\ oct\\:\\ 0\\.005414703725488416\ \(0\)\
\-\ which\\:\\ 0\\.005322217402620516\ \(0\)\
\-\ often\\:\\ 0\\.005198233648273884\ \(0\)\
\-\ mediastinal\\:\\ 0\\.005187987537834713\ \(0\)\
\-\ shortness\\:\\ 0\\.005140842610421602\ \(0\)\
\-\ pa\\:\\ 0\\.005110254636187115\ \(0\)\
\-\ image\\:\\ 0\\.005089016522969687\ \(0\)\
\-\ to\\:\\ 0\\.005088990806041304\ \(0\)\
\-\ low\\-grade\\:\\ 0\\.004987606754538025\ \(0\)\
\-\ at\\:\\ 0\\.004966572152280599\ \(0\)\
\-\ 77\\:\\ 0\\.004961487618038392\ \(0\)\
\-\ healed\\:\\ 0\\.004911302934067542\ \(0\)\
\-\ uptake\\:\\ 0\\.004854599749324421\ \(0\)\
\-\ products\\:\\ 0\\.004840656630775147\ \(0\)\
\-\ noted\\:\\ 0\\.004827028571145362\ \(0\)\
\-\ or\\:\\ 0\\.004773702330618244\ \(0\)\
\-\ cardiomegaly\\:\\ 0\\.004753934249263492\ \(0\)\
\-\ abuse\\:\\ 0\\.004733432623695367\ \(0\)\
\-\ note\\:\\ 0\\.004716013623691788\ \(0\)\
\-\ ipsilateral\\:\\ 0\\.0046937065070122705\ \(0\)\
\-\ the\\:\\ 0\\.004678598290732808\ \(0\)\
\-\ active\\:\\ 0\\.004665241428567513\ \(0\)\
\-\ outpatient\\:\\ 0\\.004637058823055358\ \(0\)\
\-\ http\\:\\ 0\\.004626961770229184\ \(0\)\
\-\ following\\:\\ 0\\.0046239804707362215\ \(0\)\
\-\ work\\-up\\:\\ 0\\.004601081389325285\ \(0\)\
\-\ include\\:\\ 0\\.00457035936707395\ \(0\)\
\-\ for\\:\\ 0\\.004517829329054002\ \(0\)\
\-\ an\\:\\ 0\\.004505871741791153\ \(0\)\
\-\ case\\:\\ 0\\.004455444310932486\ \(0\)\
\-\ are\\:\\ 0\\.004441845081142428\ \(0\)\
\-\ axillary\\:\\ 0\\.004424338564414548\ \(0\)\
\-\ did\\:\\ 0\\.00441194276595747\ \(0\)\
\-\ be\\:\\ 0\\.0043967097537690675\ \(0\)\
\-\ computed\\:\\ 0\\.004300718141813468\ \(0\)\
\-\ fact\\:\\ 0\\.004287922126244221\ \(0\)\
\-\ pet\\:\\ 0\\.0042752955993137914\ \(0\)\
\-\ equal\\:\\ 0\\.004262834129754828\ \(0\)\
\-\ group\\:\\ 0\\.0042383894866534575\ \(0\)\
\-\ transfustions\\:\\ 0\\.004201867694931601\ \(0\)\
\-\ given\\:\\ 0\\.004188867100833664\ \(0\)\
\-\ minor\\:\\ 0\\.004179887154550223\ \(0\)\
\-\ thickening\\:\\ 0\\.004141979842268853\ \(0\)\
\-\ \\(\\:\\ 0\\.004131716260689383\ \(0\)\
\-\ smoking\\:\\ 0\\.004114117019672291\ \(0\)\
\-\ followed\\:\\ 0\\.004096581322276603\ \(0\)\
\-\ hilar\\:\\ 0\\.004093164773038568\ \(0\)\
\-\ \\)\\:\\ 0\\.004081245140781536\ \(0\)\
\-\ develop\\:\\ 0\\.004062575340672982\ \(0\)\
\-\ overall\\:\\ 0\\.004052593167300917\ \(0\)\
\-\ white\\:\\ 0\\.004052579903782675\ \(0\)\
\-\ initial\\:\\ 0\\.004048973512792146\ \(0\)\
\-\ disease\\:\\ 0\\.003994482958672176\ \(0\)\
\-\ lab\\:\\ 0\\.0039854999387386675\ \(0\)\
\-\ surgery\\:\\ 0\\.003956146929190229\ \(0\)\
\-\ represents\\:\\ 0\\.0039141927766007285\ \(0\)\
\-\ home\\:\\ 0\\.0038721908797522725\ \(0\)\
\-\ 170\\.2cm\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ 34\\.1\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ 129\\/64\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ wheezez\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ coolness\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ muslce\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ supervision\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ effusion\\/thickening\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ post\\-sternotomy\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ basolateral\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ mediport\\-type\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ pleural\\-parenchymal\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ quadruple\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ almethicone\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ 125mg\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ albuterol\\-ipratropium\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ senna\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ alprazolam\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ isosorbide\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ mononitrate\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ fluoxetine\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ ferrous\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ tape\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ histroy\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ 1970\\.\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ adject\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ stacks\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ fifties\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ benches\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ venting\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ asbestos\\-using\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ asbestos\\-containing\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ sucked\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ 1960s\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ plants\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ downwind\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ factories\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ coworker\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ propsed\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ plueral\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ exersion\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ insulation\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ flooring\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ 7\\-\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ investigating\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ socola\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ loaiza\\-bonilla\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ bustinza\\-linares\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ purpura\\-like\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ 2012\\:619348\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ newland\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ leukocytoclastic\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ 6\\:261\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ ty\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ kuss\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ ren\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ 32\\:1012\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ bech\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ s0rensen\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ 3\\:1359\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ tanriverdi\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ meydan\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ barutca\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ anti\\-yo\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ antibody\\-mediated\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ jpn\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ 43\\:563\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ \\/\\/www\\.nccn\\.org\\/professionals\\/physician\\_gls\\/f\\_guidelines\\.asp\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ niederhuber\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ abeloff\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ \\/\\/www\\.clinicalkey\\.com\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ osha\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ sheet\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ \\/\\/www\\.osha\\.gov\\/sl\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ tc\\/asbestos\\/hazards\\.html\\:\\ 0\\.0038714829568191386\ \(0\)\
\-\ right\\:\\ 0\\.003867819533838775\ \(0\)\
\-\ prognosis\\:\\ 0\\.0038640080926298777\ \(0\)\
\-\ b\\:\\ 0\\.003839872908660107\ \(0\)\
\-\ approximately\\:\\ 0\\.0037804830694312436\ \(0\)\
\-\ clinical\\:\\ 0\\.0037597375596749344\ \(0\)\
\-\ and\\:\\ 0\\.003689412414912008\ \(0\)\
\-\ well\\:\\ 0\\.003685569023772452\ \(0\)\
\-\ 98\\.7\\:\\ 0\\.0036782202742127682\ \(0\)\
\-\ unlabored\\:\\ 0\\.0036782202742127682\ \(0\)\
\-\ 18f\\-fdg\\:\\ 0\\.0036782202742127682\ \(0\)\
\-\ tamsulosin\\:\\ 0\\.0036782202742127682\ \(0\)\
\-\ sober\\:\\ 0\\.0036782202742127682\ \(0\)\
\-\ opthalmologic\\:\\ 0\\.0036782202742127682\ \(0\)\
\-\ settle\\:\\ 0\\.0036782202742127682\ \(0\)\
\-\ sf\\:\\ 0\\.0036782202742127682\ \(0\)\
\-\ jy\\:\\ 0\\.0036782202742127682\ \(0\)\
\-\ yong\\:\\ 0\\.0036782202742127682\ \(0\)\
\-\ fort\\:\\ 0\\.0036782202742127682\ \(0\)\
\-\ washington\\:\\ 0\\.0036782202742127682\ \(0\)\
\-\ arch\\:\\ 0\\.003666067802088177\ \(0\)\
\-\ report\\:\\ 0\\.003646411665574606\ \(0\)\
\-\ represent\\:\\ 0\\.003577620010428533\ \(0\)\
\-\ 5\\:\\ 0\\.0035750625678419874\ \(0\)\
\-\ pulmonary\\:\\ 0\\.003569900348265105\ \(0\)\
\-\ pathologic\\:\\ 0\\.003565628797647923\ \(0\)\
\-\ under\\:\\ 0\\.0035596892840629507\ \(0\)\
\-\ managing\\:\\ 0\\.0035410982187066764\ \(0\)\
\-\ low\\-dose\\:\\ 0\\.0035410982187066764\ \(0\)\
\-\ cholecystecomy\\:\\ 0\\.0035410982187066764\ \(0\)\
\-\ ranitidine\\:\\ 0\\.0035410982187066764\ \(0\)\
\-\ nitroglycerin\\:\\ 0\\.0035410982187066764\ \(0\)\
\-\ apartment\\:\\ 0\\.0035410982187066764\ \(0\)\
\-\ plastics\\:\\ 0\\.0035410982187066764\ \(0\)\
\-\ building\\:\\ 0\\.0035410982187066764\ \(0\)\
\-\ retirement\\:\\ 0\\.0035410982187066764\ \(0\)\
\-\ mile\\:\\ 0\\.0035410982187066764\ \(0\)\
\-\ 2\\:\\ 0\\.003508302185911432\ \(0\)\
\-\ when\\:\\ 0\\.003499520358840809\ \(0\)\
\-\ findings\\:\\ 0\\.003467753929056167\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.0034639989262863803\ \(0\)\
\-\ and\\/or\\:\\ 0\\.0034428138578548166\ \(0\)\
\-\ ed\\:\\ 0\\.0034428138578548166\ \(0\)\
\-\ cxr\\:\\ 0\\.003437590344256508\ \(0\)\
\-\ limited\\:\\ 0\\.003437590344256508\ \(0\)\
\-\ mid\\-thigh\\:\\ 0\\.0034347380893862715\ \(0\)\
\-\ oxycodone\\:\\ 0\\.0034347380893862715\ \(0\)\
\-\ lipitor\\:\\ 0\\.0034347380893862715\ \(0\)\
\-\ naturally\\:\\ 0\\.0034347380893862715\ \(0\)\
\-\ brakes\\:\\ 0\\.0034347380893862715\ \(0\)\
\-\ shingles\\:\\ 0\\.0034347380893862715\ \(0\)\
\-\ clothing\\:\\ 0\\.0034347380893862715\ \(0\)\
\-\ fluorodeoxyglucose\\:\\ 0\\.0034347380893862715\ \(0\)\
\-\ biological\\:\\ 0\\.0034347380893862715\ \(0\)\
\-\ wong\\:\\ 0\\.0034347380893862715\ \(0\)\
\-\ thorac\\:\\ 0\\.0034347380893862715\ \(0\)\
\-\ network\\:\\ 0\\.0034347380893862715\ \(0\)\
\-\ 05\\:\\ 0\\.0034347380893862715\ \(0\)\
\-\ distress\\:\\ 0\\.003432395296813644\ \(0\)\
\-\ 40\\:\\ 0\\.0034272284069477342\ \(0\)\
\-\ non\\:\\ 0\\.0033673162013617823\ \(0\)\
\-\ 9\\:\\ 0\\.0033673162013617823\ \(0\)\
\-\ 5\\+\\:\\ 0\\.0033478355361003065\ \(0\)\
\-\ encompassing\\:\\ 0\\.0033478355361003065\ \(0\)\
\-\ erect\\:\\ 0\\.0033478355361003065\ \(0\)\
\-\ atenolol\\:\\ 0\\.0033478355361003065\ \(0\)\
\-\ sulfate\\:\\ 0\\.0033478355361003065\ \(0\)\
\-\ vent\\:\\ 0\\.0033478355361003065\ \(0\)\
\-\ stating\\:\\ 0\\.0033478355361003065\ \(0\)\
\-\ talking\\:\\ 0\\.0033478355361003065\ \(0\)\
\-\ 2\\-6\\:\\ 0\\.0033478355361003065\ \(0\)\
\-\ mineral\\:\\ 0\\.0033478355361003065\ \(0\)\
\-\ targeted\\:\\ 0\\.0033478355361003065\ \(0\)\
\-\ thrombocytopenic\\:\\ 0\\.0033478355361003065\ \(0\)\
\-\ 2014\\.\\:\\ 0\\.0033478355361003065\ \(0\)\
\-\ 2l\\:\\ 0\\.0032743604742188678\ \(0\)\
\-\ 10mg\\:\\ 0\\.0032743604742188678\ \(0\)\
\-\ allopurinol\\:\\ 0\\.0032743604742188678\ \(0\)\
\-\ remembers\\:\\ 0\\.0032743604742188678\ \(0\)\
\-\ coating\\:\\ 0\\.0032743604742188678\ \(0\)\
\-\ park\\:\\ 0\\.0032743604742188678\ \(0\)\
\-\ 600\\:\\ 0\\.0032743604742188678\ \(0\)\
\-\ inhaled\\:\\ 0\\.0032743604742188678\ \(0\)\
\-\ plural\\:\\ 0\\.0032743604742188678\ \(0\)\
\-\ integrated\\:\\ 0\\.0032743604742188678\ \(0\)\
\-\ currently\\:\\ 0\\.003228000757876127\ \(0\)\
\-\ rheumatic\\:\\ 0\\.0032107134805942146\ \(0\)\
\-\ withdrawal\\:\\ 0\\.0032107134805942146\ \(0\)\
\-\ occupies\\:\\ 0\\.0032107134805942146\ \(0\)\
\-\ lived\\:\\ 0\\.0032107134805942146\ \(0\)\
\-\ jb\\:\\ 0\\.0032107134805942146\ \(0\)\
\-\ 2016\\.\\:\\ 0\\.0032107134805942146\ \(0\)\
\-\ moderate\\:\\ 0\\.0032032386164049537\ \(0\)\
\-\ pressure\\:\\ 0\\.0031991734126047087\ \(0\)\
\-\ extremities\\:\\ 0\\.0031951254708683396\ \(0\)\
\-\ base\\:\\ 0\\.003191094645215793\ \(0\)\
\-\ failure\\:\\ 0\\.003191094645215793\ \(0\)\
\-\ who\\:\\ 0\\.003185846152252195\ \(0\)\
\-\ these\\:\\ 0\\.0031799495118558247\ \(0\)\
\-\ patients\\:\\ 0\\.0031624040982354993\ \(0\)\
\-\ air\\-space\\:\\ 0\\.003154572853493936\ \(0\)\
\-\ mediport\\:\\ 0\\.003154572853493936\ \(0\)\
\-\ cataract\\:\\ 0\\.003154572853493936\ \(0\)\
\-\ house\\:\\ 0\\.003154572853493936\ \(0\)\
\-\ dullness\\:\\ 0\\.003154572853493936\ \(0\)\
\-\ respiration\\:\\ 0\\.003154572853493936\ \(0\)\
\-\ plays\\:\\ 0\\.003154572853493936\ \(0\)\
\-\ pursued\\:\\ 0\\.003154572853493936\ \(0\)\
\-\ cured\\:\\ 0\\.003154572853493936\ \(0\)\
\-\ sc\\:\\ 0\\.003154572853493936\ \(0\)\
\-\ je\\:\\ 0\\.003154572853493936\ \(0\)\
\-\ livingstone\\:\\ 0\\.003154572853493936\ \(0\)\
\-\ process\\:\\ 0\\.0031363827310149804\ \(0\)\
\-\ images\\:\\ 0\\.0031253839693981965\ \(0\)\
\-\ 7\\:\\ 0\\.0031213106566330526\ \(0\)\
\-\ on\\:\\ 0\\.003105347526829768\ \(0\)\
\-\ vacuum\\:\\ 0\\.0031043533512738093\ \(0\)\
\-\ predisposition\\:\\ 0\\.0031043533512738093\ \(0\)\
\-\ churchill\\:\\ 0\\.0031043533512738093\ \(0\)\
\-\ its\\:\\ 0\\.0030739098603008975\ \(0\)\
\-\ has\\:\\ 0\\.0030594851677679274\ \(0\)\
\-\ postsurgical\\:\\ 0\\.0030589242855901463\ \(0\)\
\-\ address\\:\\ 0\\.0030589242855901463\ \(0\)\
\-\ avulsed\\:\\ 0\\.0030589242855901463\ \(0\)\
\-\ plavix\\:\\ 0\\.0030589242855901463\ \(0\)\
\-\ adhesive\\:\\ 0\\.0030589242855901463\ \(0\)\
\-\ daughter\\:\\ 0\\.0030589242855901463\ \(0\)\
\-\ son\\:\\ 0\\.0030589242855901463\ \(0\)\
\-\ swallowed\\:\\ 0\\.0030589242855901463\ \(0\)\
\-\ someone\\:\\ 0\\.0030589242855901463\ \(0\)\
\-\ safety\\:\\ 0\\.0030589242855901463\ \(0\)\
\-\ think\\:\\ 0\\.0030174507979878443\ \(0\)\
\-\ pshx\\:\\ 0\\.0030174507979878443\ \(0\)\
\-\ hemicolectomy\\:\\ 0\\.0030174507979878443\ \(0\)\
\-\ quit\\:\\ 0\\.0030174507979878443\ \(0\)\
\-\ carry\\:\\ 0\\.0030174507979878443\ \(0\)\
\-\ john\\:\\ 0\\.0030174507979878443\ \(0\)\
\-\ acute\\:\\ 0\\.0030169866479120523\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.003003052961341969\ \(0\)\
\-\ diagnosed\\:\\ 0\\.002995419596563399\ \(0\)\
\-\ thoracotomy\\:\\ 0\\.0029792988877526028\ \(0\)\
\-\ cad\\:\\ 0\\.0029792988877526028\ \(0\)\
\-\ grown\\:\\ 0\\.0029792988877526028\ \(0\)\
\-\ occuring\\:\\ 0\\.0029792988877526028\ \(0\)\
\-\ encasement\\:\\ 0\\.0029792988877526028\ \(0\)\
\-\ bj\\:\\ 0\\.0029792988877526028\ \(0\)\
\-\ elsevier\\:\\ 0\\.0029792988877526028\ \(0\)\
\-\ iv\\:\\ 0\\.002972759711593035\ \(0\)\
\-\ risk\\:\\ 0\\.0029506259746035143\ \(0\)\
\-\ bronchitis\\:\\ 0\\.0029439757361064056\ \(0\)\
\-\ 2003\\.\\:\\ 0\\.0029439757361064056\ \(0\)\
\-\ understood\\:\\ 0\\.0029439757361064056\ \(0\)\
\-\ trials\\:\\ 0\\.0029439757361064056\ \(0\)\
\-\ eds\\:\\ 0\\.0029439757361064056\ \(0\)\
\-\ of\\:\\ 0\\.002943137007766152\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.0029198720544717496\ \(0\)\
\-\ asbestosis\\:\\ 0\\.0029110906686674394\ \(0\)\
\-\ broken\\:\\ 0\\.0029110906686674394\ \(0\)\
\-\ fail\\:\\ 0\\.0029110906686674394\ \(0\)\
\-\ al\\.\\:\\ 0\\.0029110906686674394\ \(0\)\
\-\ 2017\\:\\ 0\\.0029110906686674394\ \(0\)\
\-\ 1\\:\\ 0\\.002907521021868027\ \(0\)\
\-\ would\\:\\ 0\\.0028989198078380263\ \(0\)\
\-\ obtained\\:\\ 0\\.002895963871061813\ \(0\)\
\-\ weighs\\:\\ 0\\.0028803287424817524\ \(0\)\
\-\ wires\\:\\ 0\\.0028803287424817524\ \(0\)\
\-\ former\\:\\ 0\\.0028803287424817524\ \(0\)\
\-\ discovery\\:\\ 0\\.0028803287424817524\ \(0\)\
\-\ variation\\:\\ 0\\.0028803287424817524\ \(0\)\
\-\ thrombotic\\:\\ 0\\.0028803287424817524\ \(0\)\
\-\ national\\:\\ 0\\.0028803287424817524\ \(0\)\
\-\ 3\\:\\ 0\\.0028612614776547278\ \(0\)\
\-\ yielded\\:\\ 0\\.0028514323545806874\ \(0\)\
\-\ comprehensive\\:\\ 0\\.0028514323545806874\ \(0\)\
\-\ ct\\:\\ 0\\.0028486741024595875\ \(0\)\
\-\ tall\\:\\ 0\\.0028241881153814744\ \(0\)\
\-\ issue\\:\\ 0\\.0028241881153814744\ \(0\)\
\-\ transfusions\\:\\ 0\\.0028241881153814744\ \(0\)\
\-\ polyneuropathy\\:\\ 0\\.0028241881153814744\ \(0\)\
\-\ presentation\\:\\ 0\\.002805910995701699\ \(0\)\
\-\ vertex\\:\\ 0\\.0027984172758818197\ \(0\)\
\-\ plastic\\:\\ 0\\.0027984172758818197\ \(0\)\
\-\ underwent\\:\\ 0\\.0027952297764330023\ \(0\)\
\-\ lives\\:\\ 0\\.0027739686131613476\ \(0\)\
\-\ conjunction\\:\\ 0\\.0027739686131613476\ \(0\)\
\-\ can\\:\\ 0\\.0027715286260282215\ \(0\)\
\-\ air\\:\\ 0\\.0027562084142535425\ \(0\)\
\-\ resistant\\:\\ 0\\.0027507130535000357\ \(0\)\
\-\ irritation\\:\\ 0\\.0027507130535000357\ \(0\)\
\-\ bmi\\:\\ 0\\.0027285395474776846\ \(0\)\
\-\ scars\\:\\ 0\\.0027285395474776846\ \(0\)\
\-\ excess\\:\\ 0\\.0027285395474776846\ \(0\)\
\-\ hoarseness\\:\\ 0\\.0027285395474776846\ \(0\)\
\-\ curative\\:\\ 0\\.0027285395474776846\ \(0\)\
\-\ therapies\\:\\ 0\\.0027285395474776846\ \(0\)\
\-\ gene\\:\\ 0\\.0027285395474776846\ \(0\)\
\-\ occupational\\:\\ 0\\.0027285395474776846\ \(0\)\
\-\ living\\:\\ 0\\.002707351862744208\ \(0\)\
\-\ \\.\\.\\:\\ 0\\.002707351862744208\ \(0\)\
\-\ \\'s\\:\\ 0\\.0026940609414209415\ \(0\)\
\-\ illicit\\:\\ 0\\.002687066059875382\ \(0\)\
\-\ cancer\\:\\ 0\\.0026779459145517305\ \(0\)\
\-\ seated\\:\\ 0\\.0026676084838409423\ \(0\)\
\-\ pre\\-op\\:\\ 0\\.0026676084838409423\ \(0\)\
\-\ aspirin\\:\\ 0\\.0026676084838409423\ \(0\)\
\-\ etoh\\:\\ 0\\.0026676084838409423\ \(0\)\
\-\ phenomenon\\:\\ 0\\.0026676084838409423\ \(0\)\
\-\ june\\:\\ 0\\.0026676084838409423\ \(0\)\
\-\ ppd\\:\\ 0\\.002648914149640141\ \(0\)\
\-\ specificity\\:\\ 0\\.002648914149640141\ \(0\)\
\-\ have\\:\\ 0\\.0026460029719233913\ \(0\)\
\-\ kg\\:\\ 0\\.0026309254327751045\ \(0\)\
\-\ terms\\:\\ 0\\.0026309254327751045\ \(0\)\
\-\ decades\\:\\ 0\\.002613590997993944\ \(0\)\
\-\ gradual\\:\\ 0\\.002613590997993944\ \(0\)\
\-\ orientation\\:\\ 0\\.00259686491610106\ \(0\)\
\-\ clips\\:\\ 0\\.00259686491610106\ \(0\)\
\-\ working\\:\\ 0\\.00259686491610106\ \(0\)\
\-\ oncology\\:\\ 0\\.00259686491610106\ \(0\)\
\-\ 2\\.\\:\\ 0\\.002590509191420646\ \(0\)\
\-\ mr\\:\\ 0\\.0025883693726848752\ \(0\)\
\-\ incision\\:\\ 0\\.0025807059305549772\ \(0\)\
\-\ pack\\:\\ 0\\.0025807059305549772\ \(0\)\
\-\ found\\:\\ 0\\.0025672312816512033\ \(0\)\
\-\ ongoing\\:\\ 0\\.002565076844366707\ \(0\)\
\-\ non\\-distended\\:\\ 0\\.0025499440043692903\ \(0\)\
\-\ xray\\:\\ 0\\.0025499440043692903\ \(0\)\
\-\ heat\\:\\ 0\\.0025499440043692903\ \(0\)\
\-\ infiltrates\\:\\ 0\\.0025352768648713143\ \(0\)\
\-\ web\\:\\ 0\\.0025352768648713143\ \(0\)\
\-\ 11\\.\\:\\ 0\\.0025352768648713143\ \(0\)\
\-\ after\\:\\ 0\\.002528123740623264\ \(0\)\
\-\ clubbing\\:\\ 0\\.002521047616468225\ \(0\)\
\-\ hyperlipidemia\\:\\ 0\\.002521047616468225\ \(0\)\
\-\ congestive\\:\\ 0\\.002521047616468225\ \(0\)\
\-\ bypass\\:\\ 0\\.002521047616468225\ \(0\)\
\-\ exact\\:\\ 0\\.002521047616468225\ \(0\)\
\-\ surgeons\\:\\ 0\\.002521047616468225\ \(0\)\
\-\ 2010\\:\\ 0\\.002521047616468225\ \(0\)\
\-\ 10\\.\\:\\ 0\\.002521047616468225\ \(0\)\
\-\ supraclavicular\\:\\ 0\\.0025072308686735385\ \(0\)\
\-\ medical\\:\\ 0\\.0025064917064499563\ \(0\)\
\-\ normocephalic\\:\\ 0\\.0024938033772690126\ \(0\)\
\-\ myocardial\\:\\ 0\\.0024938033772690126\ \(0\)\
\-\ during\\:\\ 0\\.0024928591515002937\ \(0\)\
\-\ rash\\:\\ 0\\.002480743809019196\ \(0\)\
\-\ remove\\:\\ 0\\.002480743809019196\ \(0\)\
\-\ some\\:\\ 0\\.0024737161619320866\ \(0\)\
\-\ roof\\:\\ 0\\.002468032537769358\ \(0\)\
\-\ production\\:\\ 0\\.002468032537769358\ \(0\)\
\-\ rhonchi\\:\\ 0\\.002455651467033771\ \(0\)\
\-\ gerd\\:\\ 0\\.002455651467033771\ \(0\)\
\-\ percussion\\:\\ 0\\.002455651467033771\ \(0\)\
\-\ projecting\\:\\ 0\\.0024435838750488854\ \(0\)\
\-\ copd\\:\\ 0\\.0024435838750488854\ \(0\)\
\-\ fingers\\:\\ 0\\.0024435838750488854\ \(0\)\
\-\ 0\\:\\ 0\\.0024435838750488854\ \(0\)\
\-\ gallops\\:\\ 0\\.002431814278961959\ \(0\)\
\-\ doing\\:\\ 0\\.0024203283153875735\ \(0\)\
\-\ e\\:\\ 0\\.0024203283153875735\ \(0\)\
\-\ primary\\:\\ 0\\.0024131403840759735\ \(0\)\
\-\ pmhx\\:\\ 0\\.0024091126350204647\ \(0\)\
\-\ role\\:\\ 0\\.0024091126350204647\ \(0\)\
\-\ never\\:\\ 0\\.0023981548093652224\ \(0\)\
\-\ clin\\:\\ 0\\.0023981548093652224\ \(0\)\
\-\ cyanosis\\:\\ 0\\.0023874432479486073\ \(0\)\
\-\ allergies\\:\\ 0\\.0023874432479486073\ \(0\)\
\-\ died\\:\\ 0\\.0023874432479486073\ \(0\)\
\-\ 9\\.\\:\\ 0\\.0023874432479486073\ \(0\)\
\-\ scarring\\:\\ 0\\.002376967124631746\ \(0\)\
\-\ social\\:\\ 0\\.002376967124631746\ \(0\)\
\-\ ultimately\\:\\ 0\\.002376967124631746\ \(0\)\
\-\ strong\\:\\ 0\\.0023667163118476836\ \(0\)\
\-\ median\\:\\ 0\\.002356681321762921\ \(0\)\
\-\ reconstruction\\:\\ 0\\.002356681321762921\ \(0\)\
\-\ post\\-operative\\:\\ 0\\.002356681321762921\ \(0\)\
\-\ spectrum\\:\\ 0\\.002356681321762921\ \(0\)\
\-\ 2008\\:\\ 0\\.002356681321762921\ \(0\)\
\-\ staging\\:\\ 0\\.0023468532535061352\ \(0\)\
\-\ rubs\\:\\ 0\\.0023372237457284805\ \(0\)\
\-\ jugular\\:\\ 0\\.0023372237457284805\ \(0\)\
\-\ unfortunately\\:\\ 0\\.0023372237457284805\ \(0\)\
\-\ s\\:\\ 0\\.0023362894824733907\ \(0\)\
\-\ changes\\:\\ 0\\.002334650120338475\ \(0\)\
\-\ syndrome\\:\\ 0\\.0023297488815392196\ \(0\)\
\-\ correction\\:\\ 0\\.0023277849338618553\ \(0\)\
\-\ bases\\:\\ 0\\.0023277849338618553\ \(0\)\
\-\ abnormal\\:\\ 0\\.0023232528506338525\ \(0\)\
\-\ affects\\:\\ 0\\.002318529411527679\ \(0\)\
\-\ \\.\\:\\ 0\\.0023181298595502573\ \(0\)\
\-\ ages\\:\\ 0\\.002309450195621724\ \(0\)\
\-\ rectal\\:\\ 0\\.002309450195621724\ \(0\)\
\-\ transformation\\:\\ 0\\.002309450195621724\ \(0\)\
\-\ time\\:\\ 0\\.002300859129875417\ \(0\)\
\-\ deformities\\:\\ 0\\.0023005406946626423\ \(0\)\
\-\ hemithorax\\:\\ 0\\.0023005406946626423\ \(0\)\
\-\ progress\\:\\ 0\\.0023005406946626423\ \(0\)\
\-\ sensitivity\\:\\ 0\\.0023005406946626423\ \(0\)\
\-\ childhood\\:\\ 0\\.0022917946800448175\ \(0\)\
\-\ floor\\:\\ 0\\.0022917946800448175\ \(0\)\
\-\ tone\\:\\ 0\\.0022832062598814816\ \(0\)\
\-\ gout\\:\\ 0\\.0022832062598814816\ \(0\)\
\-\ philadelphia\\:\\ 0\\.0022832062598814816\ \(0\)\
\-\ 8\\.\\:\\ 0\\.0022747698551629876\ \(0\)\
\-\ however\\:\\ 0\\.002268225029167846\ \(0\)\
\-\ health\\:\\ 0\\.0022583322116590935\ \(0\)\
\-\ s2\\:\\ 0\\.0022424425928470864\ \(0\)\
\-\ rales\\:\\ 0\\.0022424425928470864\ \(0\)\
\-\ htn\\:\\ 0\\.0022424425928470864\ \(0\)\
\-\ directly\\:\\ 0\\.0022346921062542453\ \(0\)\
\-\ pupils\\:\\ 0\\.0022270656327812036\ \(0\)\
\-\ morning\\:\\ 0\\.0022270656327812036\ \(0\)\
\-\ facility\\:\\ 0\\.0022270656327812036\ \(0\)\
\-\ blood\\:\\ 0\\.0022234614609240224\ \(0\)\
\-\ stated\\:\\ 0\\.0022195592662568285\ \(0\)\
\-\ male\\:\\ 0\\.002209540807274747\ \(0\)\
\-\ excluded\\:\\ 0\\.002204892126758852\ \(0\)\
\-\ murmurs\\:\\ 0\\.002190662878355763\ \(0\)\
\-\ protocol\\:\\ 0\\.002190662878355763\ \(0\)\
\-\ assessment\\:\\ 0\\.002190662878355763\ \(0\)\
\-\ literature\\:\\ 0\\.002190662878355763\ \(0\)\
\-\ up\\:\\ 0\\.002190512060108888\ \(0\)\
\-\ fissure\\:\\ 0\\.002183704442025376\ \(0\)\
\-\ survival\\:\\ 0\\.002183704442025376\ \(0\)\
\-\ therapy\\:\\ 0\\.0021779225893618806\ \(0\)\
\-\ 41\\:\\ 0\\.0021700851033961788\ \(0\)\
\-\ li\\:\\ 0\\.0021700851033961788\ \(0\)\
\-\ 7\\.\\:\\ 0\\.0021700851033961788\ \(0\)\
\-\ mild\\:\\ 0\\.002145141519476775\ \(0\)\
\-\ thick\\:\\ 0\\.0021376477996568957\ \(0\)\
\-\ evidence\\:\\ 0\\.0021357889259932105\ \(0\)\
\-\ musculoskeletal\\:\\ 0\\.002131417064877414\ \(0\)\
\-\ f\\:\\ 0\\.002125266728921309\ \(0\)\
\-\ peritoneal\\:\\ 0\\.0021191947433267288\ \(0\)\
\-\ rhythm\\:\\ 0\\.002113199136936423\ \(0\)\
\-\ suspicion\\:\\ 0\\.002113199136936423\ \(0\)\
\-\ s1\\:\\ 0\\.002101429540849497\ \(0\)\
\-\ nonspecific\\:\\ 0\\.002095651961949428\ \(0\)\
\-\ mechanism\\:\\ 0\\.002095651961949428\ \(0\)\
\-\ 5th\\:\\ 0\\.002095651961949428\ \(0\)\
\-\ drug\\:\\ 0\\.0020899435772751113\ \(0\)\
\-\ significantly\\:\\ 0\\.002084302749035358\ \(0\)\
\-\ feet\\:\\ 0\\.002084302749035358\ \(0\)\
\-\ once\\:\\ 0\\.002084302749035358\ \(0\)\
\-\ vasculitis\\:\\ 0\\.002084302749035358\ \(0\)\
\-\ factor\\:\\ 0\\.002078727896908003\ \(0\)\
\-\ confirm\\:\\ 0\\.002073217495382228\ \(0\)\
\-\ degeneration\\:\\ 0\\.0020677700712527602\ \(0\)\
\-\ began\\:\\ 0\\.0020623842012556523\ \(0\)\
\-\ anatomic\\:\\ 0\\.0020570585098361456\ \(0\)\
\-\ alcohol\\:\\ 0\\.0020517916670398707\ \(0\)\
\-\ older\\:\\ 0\\.0020517916670398707\ \(0\)\
\-\ diseases\\:\\ 0\\.0020517916670398707\ \(0\)\
\-\ movement\\:\\ 0\\.0020363315737352214\ \(0\)\
\-\ by\\:\\ 0\\.0020346104431528235\ \(0\)\
\-\ symptoms\\:\\ 0\\.0020301787196359763\ \(0\)\
\-\ progression\\:\\ 0\\.0020262965836504586\ \(0\)\
\-\ extent\\:\\ 0\\.002021357219000532\ \(0\)\
\-\ residual\\:\\ 0\\.002021357219000532\ \(0\)\
\-\ osteoarthritis\\:\\ 0\\.002021357219000532\ \(0\)\
\-\ 34\\:\\ 0\\.002021357219000532\ \(0\)\
\-\ arise\\:\\ 0\\.002016468515393673\ \(0\)\
\-\ definitive\\:\\ 0\\.0020116294441524826\ \(0\)\
\-\ hearing\\:\\ 0\\.0020068390076160183\ \(0\)\
\-\ discovered\\:\\ 0\\.0020068390076160183\ \(0\)\
\-\ expansion\\:\\ 0\\.0020068390076160183\ \(0\)\
\-\ physical\\:\\ 0\\.0019985750901632396\ \(0\)\
\-\ consistent\\:\\ 0\\.001997424469810489\ \(0\)\
\-\ interstitial\\:\\ 0\\.0019927499693693338\ \(0\)\
\-\ poorly\\:\\ 0\\.001988144673415217\ \(0\)\
\-\ dysphagia\\:\\ 0\\.001983583447954707\ \(0\)\
\-\ night\\:\\ 0\\.0019790654575092617\ \(0\)\
\-\ asymmetric\\:\\ 0\\.0019790654575092617\ \(0\)\
\-\ 6\\.\\:\\ 0\\.0019790654575092617\ \(0\)\
\-\ heent\\:\\ 0\\.00197015595655018\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.001963536226865818\ \(0\)\
\-\ suspicious\\:\\ 0\\.0019614099419323554\ \(0\)\
\-\ mediastinum\\:\\ 0\\.0019614099419323554\ \(0\)\
\-\ catheter\\:\\ 0\\.0019570963883003643\ \(0\)\
\-\ gallbladder\\:\\ 0\\.0019570963883003643\ \(0\)\
\-\ observed\\:\\ 0\\.0019528215217690197\ \(0\)\
\-\ leading\\:\\ 0\\.0019485846545539357\ \(0\)\
\-\ improved\\:\\ 0\\.0019402222571988789\ \(0\)\
\-\ become\\:\\ 0\\.0019402222571988789\ \(0\)\
\-\ relative\\:\\ 0\\.0019402222571988789\ \(0\)\
\-\ c\\:\\ 0\\.0019360954398761363\ \(0\)\
\-\ shift\\:\\ 0\\.0019320040463149388\ \(0\)\
\-\ reactive\\:\\ 0\\.0019279474735466315\ \(0\)\
\-\ visible\\:\\ 0\\.0019279474735466315\ \(0\)\
\-\ dyspnea\\:\\ 0\\.0019279474735466315\ \(0\)\
\-\ volume\\:\\ 0\\.0019239251338679544\ \(0\)\
\-\ physician\\:\\ 0\\.0019199364543300535\ \(0\)\
\-\ short\\:\\ 0\\.0019199364543300535\ \(0\)\
\-\ ordered\\:\\ 0\\.0019159808762486926\ \(0\)\
\-\ pneumothorax\\:\\ 0\\.0019120578547346242\ \(0\)\
\-\ imaging\\:\\ 0\\.0019085546467641587\ \(0\)\
\-\ work\\:\\ 0\\.001908166858243127\ \(0\)\
\-\ light\\:\\ 0\\.0019004788782956135\ \(0\)\
\-\ tumor\\:\\ 0\\.0018991728328034425\ \(0\)\
\-\ gait\\:\\ 0\\.0018966808946687418\ \(0\)\
\-\ regular\\:\\ 0\\.0018781320785344836\ \(0\)\
\-\ other\\:\\ 0\\.0018776344601548604\ \(0\)\
\-\ regions\\:\\ 0\\.0018637958272297753\ \(0\)\
\-\ decrease\\:\\ 0\\.0018637958272297753\ \(0\)\
\-\ l\\:\\ 0\\.0018567862240888337\ \(0\)\
\-\ were\\:\\ 0\\.0018496533238226132\ \(0\)\
\-\ incidentally\\:\\ 0\\.0018464613924486148\ \(0\)\
\-\ overlying\\:\\ 0\\.0018430688911288513\ \(0\)\
\-\ present\\:\\ 0\\.0018398558188099912\ \(0\)\
\-\ generally\\:\\ 0\\.0018330339010440885\ \(0\)\
\-\ poor\\:\\ 0\\.0018330339010440885\ \(0\)\
\-\ few\\:\\ 0\\.0018330339010440885\ \(0\)\
\-\ it\\:\\ 0\\.001831123340832237\ \(0\)\
\-\ gi\\:\\ 0\\.001829735310555731\ \(0\)\
\-\ factors\\:\\ 0\\.001829735310555731\ \(0\)\
\-\ year\\:\\ 0\\.0018228889785946896\ \(0\)\
\-\ medications\\:\\ 0\\.0018167645939089795\ \(0\)\
\-\ even\\:\\ 0\\.0018135763250096484\ \(0\)\
\-\ appearing\\:\\ 0\\.0018104092407776804\ \(0\)\
\-\ strength\\:\\ 0\\.0018072630615444335\ \(0\)\
\-\ necessary\\:\\ 0\\.001804137513143023\ \(0\)\
\-\ resulting\\:\\ 0\\.0017888100052142666\ \(0\)\
\-\ until\\:\\ 0\\.0017888100052142666\ \(0\)\
\-\ their\\:\\ 0\\.0017828143988239615\ \(0\)\
\-\ large\\:\\ 0\\.0017812606595148518\ \(0\)\
\-\ point\\:\\ 0\\.0017798446420314753\ \(0\)\
\-\ 60\\:\\ 0\\.0017768932739438104\ \(0\)\
\-\ development\\:\\ 0\\.0017739600682362897\ \(0\)\
\-\ bleeding\\:\\ 0\\.0017681472593259855\ \(0\)\
\-\ not\\:\\ 0\\.0017657083008702603\ \(0\)\
\-\ review\\:\\ 0\\.0017652672238369662\ \(0\)\
\-\ children\\:\\ 0\\.0017595588391626496\ \(0\)\
\-\ 5\\.\\:\\ 0\\.0017567300805736057\ \(0\)\
\-\ cerebellar\\:\\ 0\\.0017567300805736057\ \(0\)\
\-\ another\\:\\ 0\\.0017511224344441553\ \(0\)\
\-\ stage\\:\\ 0\\.0017373853331402985\ \(0\)\
\-\ but\\:\\ 0\\.0017373720696220569\ \(0\)\
\-\ skull\\:\\ 0\\.0017346847909402616\ \(0\)\
\-\ rupture\\:\\ 0\\.0017293291792782378\ \(0\)\
\-\ features\\:\\ 0\\.001718795172128254\ \(0\)\
\-\ denies\\:\\ 0\\.001718795172128254\ \(0\)\
\-\ recurrent\\:\\ 0\\.001718795172128254\ \(0\)\
\-\ general\\:\\ 0\\.001716197648406822\ \(0\)\
\-\ oral\\:\\ 0\\.001716197648406822\ \(0\)\
\-\ s\\/p\\:\\ 0\\.0017084889452392332\ \(0\)\
\-\ outside\\:\\ 0\\.0017084889452392332\ \(0\)\
\-\ arm\\:\\ 0\\.0017059468356227592\ \(0\)\
\-\ traumatic\\:\\ 0\\.0017059468356227592\ \(0\)\
\-\ procedure\\:\\ 0\\.0017059468356227592\ \(0\)\
\-\ just\\:\\ 0\\.0017009029322240287\ \(0\)\
\-\ position\\:\\ 0\\.0016959118455379964\ \(0\)\
\-\ absence\\:\\ 0\\.0016934357650436667\ \(0\)\
\-\ references\\:\\ 0\\.0016934357650436667\ \(0\)\
\-\ respiratory\\:\\ 0\\.0016909724808880696\ \(0\)\
\-\ administration\\:\\ 0\\.0016909724808880696\ \(0\)\
\-\ history\\:\\ 0\\.0016876280329462584\ \(0\)\
\-\ i\\:\\ 0\\.0016836581006808911\ \(0\)\
\-\ films\\:\\ 0\\.0016812447060400204\ \(0\)\
\-\ related\\:\\ 0\\.0016812447060400204\ \(0\)\
\-\ nodule\\:\\ 0\\.0016788434696101077\ \(0\)\
\-\ thin\\:\\ 0\\.0016740769856565408\ \(0\)\
\-\ many\\:\\ 0\\.0016740769856565408\ \(0\)\
\-\ increasing\\:\\ 0\\.0016693576953883272\ \(0\)\
\-\ family\\:\\ 0\\.0016693576953883272\ \(0\)\
\-\ pathology\\:\\ 0\\.0016670154576369312\ \(0\)\
\-\ 12\\:\\ 0\\.0016670154576369312\ \(0\)\
\-\ infarction\\:\\ 0\\.00166468467341663\ \(0\)\
\-\ initially\\:\\ 0\\.001657759935302755\ \(0\)\
\-\ placement\\:\\ 0\\.0016531987098422447\ \(0\)\
\-\ treatment\\:\\ 0\\.0016488245563402164\ \(0\)\
\-\ visualized\\:\\ 0\\.0016486807193967995\ \(0\)\
\-\ reports\\:\\ 0\\.001641983029475136\ \(0\)\
\-\ attenuation\\:\\ 0\\.0016375696236539746\ \(0\)\
\-\ shown\\:\\ 0\\.0016331967083651083\ \(0\)\
\-\ typical\\:\\ 0\\.0016331967083651083\ \(0\)\
\-\ additional\\:\\ 0\\.0016331967083651083\ \(0\)\
\-\ sounds\\:\\ 0\\.0016245694244548996\ \(0\)\
\-\ complications\\:\\ 0\\.0016140003789380634\ \(0\)\
\-\ also\\:\\ 0\\.0016059290692756448\ \(0\)\
\-\ worsening\\:\\ 0\\.001603660615062344\ \(0\)\
\-\ 4\\.\\:\\ 0\\.001603660615062344\ \(0\)\
\-\ colon\\:\\ 0\\.0015995867063023543\ \(0\)\
\-\ rate\\:\\ 0\\.0015875698238683714\ \(0\)\
\-\ change\\:\\ 0\\.0015875698238683714\ \(0\)\
\-\ midline\\:\\ 0\\.0015758484687028221\ \(0\)\
\-\ about\\:\\ 0\\.0015700941401831515\ \(0\)\
\-\ skin\\:\\ 0\\.001564408453402754\ \(0\)\
\-\ result\\:\\ 0\\.001562528196829343\ \(0\)\
\-\ cough\\:\\ 0\\.0015606553283165263\ \(0\)\
\-\ pattern\\:\\ 0\\.0015569315248194844\ \(0\)\
\-\ within\\:\\ 0\\.001553986089977199\ \(0\)\
\-\ cardiac\\:\\ 0\\.0015513998059823498\ \(0\)\
\-\ lungs\\:\\ 0\\.0015423205900763944\ \(0\)\
\-\ referred\\:\\ 0\\.0015369549301504487\ \(0\)\
\-\ course\\:\\ 0\\.0015369549301504487\ \(0\)\
\-\ tumors\\:\\ 0\\.0015298934021308393\ \(0\)\
\-\ metastasis\\:\\ 0\\.0015246650744994883\ \(0\)\
\-\ appears\\:\\ 0\\.0015160766543361529\ \(0\)\
\-\ sided\\:\\ 0\\.001505970740298687\ \(0\)\
\-\ clear\\:\\ 0\\.001505970740298687\ \(0\)\
\-\ since\\:\\ 0\\.0014960746528590164\ \(0\)\
\-\ abnormalities\\:\\ 0\\.0014960746528590164\ \(0\)\
\-\ involvement\\:\\ 0\\.001492821094674841\ \(0\)\
\-\ early\\:\\ 0\\.0014895895946818102\ \(0\)\
\-\ reported\\:\\ 0\\.0014847830555652106\ \(0\)\
\-\ vein\\:\\ 0\\.001473752775030561\ \(0\)\
\-\ including\\:\\ 0\\.0014706475886524899\ \(0\)\
\-\ care\\:\\ 0\\.0014691025486505017\ \(0\)\
\-\ they\\:\\ 0\\.0014675625007089161\ \(0\)\
\-\ 20\\:\\ 0\\.001464497252696385\ \(0\)\
\-\ biopsy\\:\\ 0\\.001445039676661945\ \(0\)\
\-\ typically\\:\\ 0\\.0014377625212135235\ \(0\)\
\-\ being\\:\\ 0\\.0014193460327934025\ \(0\)\
\-\ heart\\:\\ 0\\.0014151952568678618\ \(0\)\
\-\ inflammatory\\:\\ 0\\.001412448019157304\ \(0\)\
\-\ side\\:\\ 0\\.0014110803154261538\ \(0\)\
\-\ benign\\:\\ 0\\.0014056484113599624\ \(0\)\
\-\ 3\\.\\:\\ 0\\.0013936483375313286\ \(0\)\
\-\ now\\:\\ 0\\.0013923334555298605\ \(0\)\
\-\ neoplasm\\:\\ 0\\.0013871099027225587\ \(0\)\
\-\ inferior\\:\\ 0\\.001381942974908991\ \(0\)\
\-\ fever\\:\\ 0\\.0013781042071267713\ \(0\)\
\-\ although\\:\\ 0\\.0013755620975102972\ \(0\)\
\-\ type\\:\\ 0\\.0013730334739499095\ \(0\)\
\-\ 10\\:\\ 0\\.0013730334739499095\ \(0\)\
\-\ internal\\:\\ 0\\.0013655271074255345\ \(0\)\
\-\ size\\:\\ 0\\.0013655271074255345\ \(0\)\
\-\ cases\\:\\ 0\\.0013569165223932947\ \(0\)\
\-\ out\\:\\ 0\\.0013460695313910944\ \(0\)\
\-\ study\\:\\ 0\\.0013401484065109434\ \(0\)\
\-\ bilaterally\\:\\ 0\\.0013378003996777422\ \(0\)\
\-\ radiation\\:\\ 0\\.0013366307195244692\ \(0\)\
\-\ revealed\\:\\ 0\\.0013071848855415124\ \(0\)\
\-\ medial\\:\\ 0\\.0013028119702526463\ \(0\)\
\-\ superior\\:\\ 0\\.0013006404657074314\ \(0\)\
\-\ follow\\:\\ 0\\.0012941846863424376\ \(0\)\
\-\ day\\:\\ 0\\.0012931171731901474\ \(0\)\
\-\ adjacent\\:\\ 0\\.001287815178329012\ \(0\)\
\-\ any\\:\\ 0\\.0012825715124272134\ \(0\)\
\-\ while\\:\\ 0\\.0012815296662785098\ \(0\)\
\-\ normal\\:\\ 0\\.001277037611629267\ \(0\)\
\-\ will\\:\\ 0\\.0012742998181025462\ \(0\)\
\-\ 1\\.\\:\\ 0\\.0012722541307424217\ \(0\)\
\-\ show\\:\\ 0\\.0012503126475174576\ \(0\)\
\-\ age\\:\\ 0\\.0012397094020706893\ \(0\)\
\-\ diffuse\\:\\ 0\\.0012330826598547734\ \(0\)\
\-\ only\\:\\ 0\\.001224695738076709\ \(0\)\
\-\ renal\\:\\ 0\\.0012237729025062294\ \(0\)\
\-\ treated\\:\\ 0\\.0012191853365509338\ \(0\)\
\-\ 6\\:\\ 0\\.0012164538424093777\ \(0\)\
\-\ negative\\:\\ 0\\.0012164538424093777\ \(0\)\
\-\ decreased\\:\\ 0\\.0012110373702214296\ \(0\)\
\-\ abdomen\\:\\ 0\\.0012065701920379868\ \(0\)\
\-\ neck\\:\\ 0\\.0011960167478639095\ \(0\)\
\-\ evaluation\\:\\ 0\\.0011831452792310808\ \(0\)\
\-\ loss\\:\\ 0\\.0011822994149039273\ \(0\)\
\-\ wall\\:\\ 0\\.0011797707913435396\ \(0\)\
\-\ appearance\\:\\ 0\\.0011648744407696098\ \(0\)\
\-\ axial\\:\\ 0\\.0011624363565623792\ \(0\)\
\-\ fluid\\:\\ 0\\.0011575972853211883\ \(0\)\
\-\ weeks\\:\\ 0\\.0011559951176840554\ \(0\)\
\-\ edema\\:\\ 0\\.0011520131026841233\ \(0\)\
\-\ all\\:\\ 0\\.0011520131026841233\ \(0\)\
\-\ likely\\:\\ 0\\.0011488512707033634\ \(0\)\
\-\ chronic\\:\\ 0\\.0011472781853703526\ \(0\)\
\-\ 4\\:\\ 0\\.0011348769805429196\ \(0\)\
\-\ months\\:\\ 0\\.0011124601023308233\ \(0\)\
\-\ presented\\:\\ 0\\.0011102753265121112\ \(0\)\
\-\ been\\:\\ 0\\.0011081005192869356\ \(0\)\
\-\ distal\\:\\ 0\\.0011073777831010613\ \(0\)\
\-\ if\\:\\ 0\\.0011052161266828576\ \(0\)\
\-\ due\\:\\ 0\\.0010868813884427262\ \(0\)\
\-\ prior\\:\\ 0\\.0010458116168743392\ \(0\)\
\-\ both\\:\\ 0\\.0010401334559991045\ \(0\)\
\-\ over\\:\\ 0\\.0010370079075976942\ \(0\)\
\-\ with\\:\\ 0\\.0010038489845653076\ \(0\)\
\-\ increased\\:\\ 0\\.0009964179131552219\ \(0\)\
\-\ into\\:\\ 0\\.000969173673956009\ \(0\)\
\-\ associated\\:\\ 0\\.0009611356348463784\ \(0\)\
\-\ most\\:\\ 0\\.0009403408683165281\ \(0\)\
\-\ small\\:\\ 0\\.0009383104310682166\ \(0\)\
\-\ demonstrate\\:\\ 0\\.0009372984467745666\ \(0\)\
\-\ contrast\\:\\ 0\\.0009117138640647785\ \(0\)\
\-\ exam\\:\\ 0\\.0008947730886318103\ \(0\)\
\-\ lateral\\:\\ 0\\.0008802040255598429\ \(0\)\
\-\ had\\:\\ 0\\.0008788607336704996\ \(0\)\
\-\ \\-\\:\\ 0\\.0008730831547704306\ \(0\)\
\-\ female\\:\\ 0\\.0008373499863907691\ \(0\)\
\-\ old\\:\\ 0\\.0008340653926236936\ \(0\)\
\-\ mass\\:\\ 0\\.0005664733112238153\ \(0\)\
\-\ pain\\:\\ 0\\.0004974300131223711\ \(0\)\
\-\ left\\:\\ 0\\.0004557222446486724\ \(0\)\
